ACLARION, INC. Adjustments to Additional Paid in Capital, Other
ACLARION, INC. (ACON) reported Adjustments to Additional Paid in Capital, Other of $698.06 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-06
- ACLARION, INC. adjustments to additional paid in capital, other for the quarter ending 2026-06-30 was $6.33K, a 65.15% decline year-over-year.
- ACLARION, INC. adjustments to additional paid in capital, other for the quarter ending 2026-03-31 was $691.74K, a 67.06% decline year-over-year.
- ACLARION, INC. adjustments to additional paid in capital, other for the quarter ending 2025-12-31 was $281.85K.
- ACLARION, INC. adjustments to additional paid in capital, other for the quarter ending 2025-09-30 was $0.00.
- ACLARION, INC. adjustments to additional paid in capital, other for fiscal 2025 was $2.40M, a 118.18% increase from fiscal 2024.
- ACLARION, INC. adjustments to additional paid in capital, other for fiscal 2024 was $1.10M.
- ACLARION, INC. adjustments to additional paid in capital, other for fiscal 2022 was -$530.46K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $698.06K 10-Q · filed 2026-08-06 | $979.91K derived: sum of 3 quarters · filed 2026-08-06 | $979.91K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $691.74K 10-Q · filed 2026-05-13 | $973.59K derived: sum of 2 quarters · filed 2026-05-13 | $973.59K derived: sum of 3 quarters · filed 2026-05-13 | $991.74K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | $281.85K derived: 10-K 12 month − 3 quarters · filed 2026-03-18 | $281.85K derived: sum of 2 quarters · filed 2026-03-18 | $300.00K derived: sum of 3 quarters · filed 2026-03-18 | $2.40M 10-K · filed 2026-03-18 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $18.15K derived: sum of 2 quarters · filed 2025-11-12 | $2.12M derived: sum of 3 quarters · filed 2025-11-12 | |
| 2025-06-30 | $18.15K 10-Q · filed 2025-08-14 | $2.12M derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2025-03-31 | $2.10M 10-Q · filed 2025-11-12 | |||
| 2024-12-31 | $1.10M 10-K · filed 2026-03-18 | |||
| 2023-06-30 | $37.50K 10-Q · filed 2023-08-25 | |||
| 2022-12-31 | -$530.46K 10-K · filed 2024-03-28 | |||
| 2022-06-30 | -$530.46K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |